We at HHS are working with President Trump on a comprehensive plan to bring down the high price of prescription drugs.
I'd never have guessed that, six years after Medicare introduced a drug benefit, it would still be forbidden to negotiate prices with pharmaceutical companies. Health reform might fix that, but it probably won't.
The rising cost of prescription drugs has sparked a prairie fire that is spreading across our nation.
To drive down high drug costs, we need to shine a light on the negotiations between drug manufacturers, middleman negotiators and pharmacies.
One of the biggest factors fueling the angst over drug prices in the U.S. is that some older medicines that should be sold cheaply as generics are still priced very high, often owing to a dwindling number of generic competitors and the rising cost of producing these drugs.
With the Lower Drug Costs Now Act, we are taking bold action to level the playing field for American patients and taxpayers. This legislation is one that I am proud to have voted for, and the House can be proud to have passed. It is essential to save the lives of Americans and improve our quality of life.
It's crucial to keep in mind that the hundreds of millions of dollars now spent on prescription drug advertisements are ultimately paid for by consumers in the form a higher drug prices.
With the skyrocketing costs of prescription drugs, American taxpayers shouldn't be footing the bill for medicine going to waste.
The status quo on prescription drug prices is deeply broken and unsustainable.
There are no issues more personal than prescription drugs and the high prices Americans must pay to get the medicine they need.
We can't just say the right thing on lowering the cost of prescription drugs: we have to do the right thing, too.
I support negotiating authority to lower prescription drug prices.
If Americans could legally access prescription drugs outside the United States, then drug companies would be forced to re-evaluate their pricing strategy.
I think we can build broad bipartisan support for bringing down prescription drug costs.
I'm offering solutions to address rising healthcare prices by adding transparency to our drug pricing, clearing the backlog on pending drug applications at the FDA, and providing oversight and accountability within the healthcare industry.
Proposing direct discounts at the pharmacy counter is just part of the Trump agenda for fairer, more transparent prices in health care.
How long do we have to keep fighting for affordable prescription drugs?
If the U.S. can transform its domestic market for HIV/AIDS drugs, it will certainly transform the world market and make HIV/AIDS drugs more affordable for everyone, everywhere.
